Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Evaluating Single Agent Indocyanine Green as an Alternative to Dual Dye‐Tracer Mapping in Sentinel Lymph Node Biopsy for Breast Cancer: A Two‐Arm Open‐Label Randomized Controlled Trial
1
Zitationen
11
Autoren
2026
Jahr
Abstract
This study is registered under Clinical Trials Registry-India (CTRI) vide registration no. CTRI/2022/09/045719.
Ähnliche Arbeiten
New Guidelines to Evaluate the Response to Treatment in Solid Tumors
2000 · 15.699 Zit.
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 · 13.213 Zit.
Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2
2001 · 11.469 Zit.
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
2001 · 10.905 Zit.
Gene expression profiling predicts clinical outcome of breast cancer
2002 · 9.587 Zit.